Eversept Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-167,243	Closed	-$18.5M	–	69
2025 Q1	$18.5M	Buy	+167,243	New	+$18.5M	1.88%	17